Since joining NIAMS in 2021, I have been struck by how much our mission is driven by meaningful interactions with patient advocacy and other community groups interested in research related to bones, joints, muscles, and skin.

Mariana Kaplan, M.D., a longstanding NIAMS researcher and leader, has been promoted to the title of NIH Distinguished Investigator.

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation, pain, and stiffness. There are several treatment options to control inflammation, but response to therapy varies and some people with RA never reach remission, suggesting there may be different drivers of inflammation.

The K Forum brings together clinician-scientists with a NIAMS K08 or K23 award.

Research from NIAMS’ Michael Ombrello is a focus of a recent essay in The New Yorker: "Nobody Has My Condition But Me," by Beverly Gage.

Recently, a small IRP study showed that exercise training can help reduce the debilitating fatigue that often accompanies the autoimmune disease known as lupus, and also illuminated some of the underlying mechanisms that may lead to those benefits.

As many as 2.5 million Americans live with myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS for short. It’s a serious disease that can often arise after an infection, leaving people profoundly ill for decades with pain, cognitive difficulties, severe fatigue, and other debilitating symptoms.

In 2020, a team of NIH researchers reported the discovery of a rare and often-deadly inflammatory disorder, which they named VEXAS. Affected people have varying symptoms that can include anemia, recurrent fevers, painful rashes, blood clots, and shortness of breath.